Tecentriq (atezolizumab) is an immunotherapy medication that’s used to treat several different types of cancer, like lung cancer, liver cancer, and melanoma. It turns on your immune system to fight cancer. But this can sometimes cause side effects like rash, diarrhea, and lung problems that might need temporary treatment with corticosteroids. Tecentriq (atezolizumab) is given through the vein (intravenously, IV) at an infusion center or provider’s office.
Your immune system plays an important role in our body, for example, to fight infections. The immune system also attacks and kills cancer cells that it recognizes as abnormal. Some cancer cells can hide from the immune system by using the programmed death-1 (PD-1) pathway. When a cancer cell uses the PD-1 pathway, it stops our immune cells from attacking the cancer cells. This allows the cancer to grow.
Tecentriq (atezolizumab) is an immunotherapy medication known as a PD-L1 inhibitor. It blocks the PD-1 pathway, which helps the immune system recognize and attack cancer cells. As a result, the immune system can kill the cancer cells and stop the cancer from growing.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Note: Side effects were reported in people with NSCLC taking Tecentriq (atezolizumab) by itself. Side effects might differ for people with other cancers and those receiving chemotherapy along with Tecentriq (atezolizumab).
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Immunotherapy medications like Tecentriq (atezolizumab) help our immune system work. The immune system can usually recognize abnormal cells in the body, such as bacteria and cancer cells. It attacks and kills these cells to protect the body from harm. Some cancer cells are able to hide from the immune system. This allows the cancer cells to keep growing. Immunotherapy medications, such as Tecentriq (atezolizumab), help turn on or activate your immune system to fight and kill cancer cells.
Immunotherapy is a unique type of cancer treatment that doesn’t usually cause the side effects most people expect with chemotherapy, such as nausea or hair loss. Because immunotherapy like Tecentriq (atezolizumab) works differently than traditional chemotherapy, its side effects are different. They’re called immune-related adverse events (irAEs). These side effects happen when the immune system becomes too active during treatment and starts to attack healthy cells in addition to cancer cells. This immune reaction is very similar to symptoms of an autoimmune disease. The most common reactions affect the skin (i.e., rash), gut (i.e., diarrhea), and lungs (i.e., trouble breathing). Let your provider know if you have these side effects during treatment with Tecentriq (atezolizumab) so they can help you manage them.
It depends on how severe the side effect is. Tell your provider if you have symptoms of an immune-related side effect, such as diarrhea, a new rash, trouble breathing, or sudden tiredness. They’ll need to examine you to decide what the next steps are. Sometimes, your provider will pause your Tecentriq (atezolizumab) treatment for a few weeks and give you a corticosteroid medication (like prednisone or dexamethasone) to take to calm your immune system down. If you’re taking other medications with Tecentriq (atezolizumab) to treat your cancer, you might be able to continue those while you’re on a break from Tecentriq (atezolizumab). Once the side effect gets better, you might be able to restart Tecentriq (atezolizumab). Other times, these side effects are serious enough that you have to stop Tecentriq (atezolizumab) altogether.
Tecentriq (atezolizumab) by itself doesn’t typically cause nausea in most people. However, sometimes (like when treating lung cancer), Tecentriq (atezolizumab) is given along with chemotherapy medications that commonly cause nausea. Depending on the type of treatment you’re taking, your provider might prescribe medications like ondansetron (Zofran) to prevent or treat nausea. Talk to your provider if you’re concerned about nausea with treatment.
How long you need to take Tecentriq (atezolizumab) depends on several factors. These factors include what type of cancer you have, what other medications you’re taking, and how well Tecentriq (atezolizumab) is working to treat your cancer. Your provider will monitor how well your medication is working for you based on your scan results and your symptom improvement during treatment. How long your treatment with Tecentriq (atezolizumab) is also depends on whether you have any side effects from the medication (e.g., diarrhea, rash, cough) and how severe they are. If you’re unsure about how long you should take Tecentriq (atezolizumab), discuss it with your provider.
Tecentriq (atezolizumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Side effects from immunotherapy like Tecentriq (atezolizumab) are typically called immune-related adverse events (irAEs). They happen when the immune system becomes too active and doesn’t just attack cancer cells; it attacks healthy cells, too. These side effects can happen anywhere in your body. They can be mild or very serious. And they can happen at any time during treatment.
You might notice certain immune-related side effects, like diarrhea, skin rash, or shortness of breath. Call your provider right away if you experience any of these symptoms. You might need to pause or stop Tecentriq (atezolizumab) and take a corticosteroid depending on how severe your symptoms are. Other side effects, like changes in lab values that show how well your liver and kidneys are working, might not cause noticeable symptoms. You’ll need blood tests done often so your provider can monitor for those side effects closely.
Some people taking Tecentriq (atezolizumab) have experienced reactions during their infusion. If you feel itchy or warm, have trouble breathing, feel nauseous, or suddenly have a fast heart rate while receiving Tecentriq (atezolizumab), let your nurse know right away. Most of the time, giving the infusion slower can help. But sometimes, having a serious reaction means that you shouldn’t take Tecentriq (atezolizumab) again to avoid having another reaction in the future.
Some people who’ve taken immunotherapy medications like Tecentriq (atezolizumab) and who’ve also had a stem cell transplant have experienced serious problems like graft-versus-host-disease. Let your provider know if you’ve had a stem cell transplant before taking Tecentriq (atezolizumab). Also notify your provider if you’re planning to have a stem cell transplant after treatment with Tecentriq (atezolizumab). Your provider will follow up with you closely for signs and symptoms of these problems.
Based on animal studies, Tecentriq (atezolizumab) might harm an unborn baby or raise the risk for miscarriage (pregnancy loss) when taken during pregnancy. Because of these risks, if you’re able to get pregnant, you should use birth control while taking Tecentriq (atezolizumab) and for at least 5 months after the last dose. Let your provider know right away if you become pregnant while taking Tecentriq (atezolizumab).
This medication is given as an injection into the vein (IV) by a healthcare provider.
Adults: For most cancers, there are a few dosing options your healthcare team will decide to use for your Tecentriq (atezolizumab) treatment. Dosing options include 840 mg given every 2 weeks; 1,200 mg given every 3 weeks; or 1,680 mg given every 4 weeks. Which option your provider chooses will depend on your specific cancer diagnosis and whether you’re taking Tecentriq (atezolizumab) with other anticancer medications.
Children 2 years and older (ASPS only): The dose is based on your child’s body weight. The typical dose is 15 mg/kg given every 3 weeks. Each dose can be up to a maximum of 1,200 mg.